Dr Reddys Laboratories (RDY) Market Capitalization (2009 - 2026)

Dr Reddys Laboratories has reported Market Capitalization for 18 years, with the latest figure at $12.1 billion in Q2 2026.

• On a quarterly basis, Market Capitalization fell 3.57% year-over-year to $12.1 billion in Q2 2026; TTM through Jun 2026 was $12.1 billion, a 3.57% decrease from a year earlier, with the FY2026 full-year figure at $11.6 billion, up 5.03% from the prior year.
• Market Capitalization was $12.1 billion for Q2 2026 at Dr Reddys Laboratories, up from $11.6 billion in the prior quarter.
• The five-year high for Market Capitalization was $13.3 billion in Q3 2024, with the low at $8.6 billion in Q4 2022.
• Average Market Capitalization over 5 years is $11.1 billion, with a median of $11.6 billion recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Market Capitalization fell 24.59% in 2022, then surged 34.54% in 2023.
• Over 5 years, Market Capitalization stood at $8.6 billion in 2022, then jumped by 34.54% to $11.6 billion in 2023, then advanced by 13.66% to $13.2 billion in 2024, then retreated by 11.04% to $11.7 billion in 2025, then advanced by 3.23% to $12.1 billion in 2026.
• The last three Market Capitalization figures came in at $12.1 billion (Q2 2026), $11.6 billion (Q1 2026), and $11.7 billion (Q4 2025), per Business Quant data.